Clinical Trials List
2023-02-01 - 2025-12-31
Phase III
Recruiting5
Terminated1
ICD-10E78.1
Pure hyperglyceridemia
ICD-9272.1
Pure hyperglyceridemia
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳韋璁 無
- Ye-Hsu Lu 無
- Mei Yueh Lee 無
- Chun-Yuan Chu 無
- 趙敏芳 未分科
- Jui-Sheng Hsu 無
- Po-Chao Hsu 無
- 洪薇雯 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 杜業豐 未分科
- Po-Sheng Chen 無
- Shih-Hung Chan 無
- 周宣彣 無
- Ju-Yi Chen 無
- Ting-Hsing Chao 無
- Po-Tseng Lee 未分科
- 張獻元 無
- 黃鼎鈞 無
- Horng-Yih Ou 無
- Cheng-Han Lee 未分科
- 林景翰 無
- 黃睦祥 無
- Yen-Wen Liu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
390 participants
